Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Clinical Breast Cancer|August 21, 2019
First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysisAngela Toss, Marta Venturelli, Isabella Sperduti, et al.
BMC Cancer|June 7, 2022
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysisClaudia Omarini, Federico Piacentini, Isabella Sperduti, et al.
JCO Global Oncology|July 1, 2025
Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of Randomized Phase III Trials of the Last DecadeEmma Zattarin, Luca Moscetti, Elisa D'Agostino, et al.
The Oncologist|July 25, 2008
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient managementValentina Guarneri, Simona Giovannelli, Guido Ficarra, et al.
Current Drug Targets|March 9, 2016
Tumor Stroma Manipulation By MSCGiulia Grisendi, Carlotta Spano, Filippo Rossignoli, et al.
Cancers|October 13, 2021
Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the LiteratureChrystel Isca, Federico Piacentini, Ilenia Mastrolia, et al.
Clinical Breast Cancer|July 28, 2023
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World SettingRaffaella D'Onofrio, Claudia Omarini, Angela Toss, et al.
Haematologica|June 4, 2008
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumorRita Santachiara, Rossana Maffei, Silvia Martinelli, et al.
Breast Cancer (Dove Medical Press)|January 27, 2025
Update on Pulmonary Toxicity Induced by New Breast Cancer TreatmentsLorenzo Belluzzi, Giulio Martinelli, Bianca Medici, et al.
Cancer Biology & Therapy|August 2, 2018
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patientsClaudia Omarini, Stefania Bettelli, Cecilia Caprera, et al.
Pageof 8